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Guangzhou Biobank Cohort Study
Douglas A West1, Gabriel M Leung1, Chao Q Jiang2, Timothy M Elwell-Sutton1, Wei S Zhang2, Tai H Lam1*,
Kar K Cheng3 and C Mary Schooling1
Abstract
Background: Socioeconomic position (SEP) throughout life is associated with cardiovascular disease, though the
mechanisms linking these two are unclear. It is also unclear whether there are critical periods in the life course
when exposure to better socioeconomic conditions confers advantages or whether SEP exposures accumulate
across the whole life course. Inflammation may be a mechanism linking socioeconomic position (SEP) with
cardiovascular disease. In a large sample of older residents of Guangzhou, in southern China, we examined the
association of life course SEP with inflammation.
Methods: In baseline data on 9,981 adults (≥ 50 years old) from the Guangzhou Biobank Cohort Study (2006-08),
we used multivariable linear regression and model fit to assess the associations of life course SEP at four stages
(childhood, early adult, late adult and current) with white blood, granulocyte and lymphocyte cell counts.
Results: A model including SEP at all four life stages best explained the association of life course SEP with white
blood and granulocyte cell count for men and women, with early adult SEP (education) making the largest
contribution. A critical period model best explained the association of life course SEP with lymphocyte count, with
sex-specific associations. Early adult SEP was negatively associated with lymphocytes for women.
Conclusions: Low SEP throughout life may negatively impact late adult immune-inflammatory status. However,
some aspects of immune-inflammatory status may be sensitive to earlier exposures, with sex-specific associations.
The findings were compatible with the hypothesis that in a developing population, upregulation of the
gonadotropic axis with economic development may obscure the normally protective effects of social advantage
for men.
Background
Socioeconomic position (SEP) throughout life is usually
inversely associated with morbidity and mortality from
cardiovascular disease, although the underlying biological
pathway is not entirely clear [1,2]. Cardiovascular disease
has been associated with higher levels of inflammatory
molecules, perhaps as a consequence of exposure to
pathogenic organisms [3], although it is unclear whether
pathogen burden mediates SEP differences in cardiovas-
cular risk [3,4]. Poor early life conditions are usually asso-
ciated with higher levels of inflammatory markers [5-11]
and poorer adult immune function [12,13]. These asso-
ciations are less clear, however, amongst men from mid-
dle income countries [10]. Furthermore, little is known
about the association of SEP across the life course with
immune function. The duration or number of exposures
across the life course may be most important (the accu-
mulation hypothesis) [14]. Alternatively, the timing of
exposure to poor socioeconomic conditions may be cru-
cial as a number of sensitive periods or simply as a single
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critical period (the critical period hypothesis). It is also
possible that either inter- or intra-generational social
mobility plays a part.
Developmental trade-offs between growth, maintenance,
and reproduction may occur when there are competing
demands for energy resources between biological systems
[13,15,16], potentially at the expense of immune function
in resource-poor environments. Alternatively, intergenera-
tionally and environmentally driven up-regulation of the
gonadotropic axis with economic development may
obscure some of the normally protective effects of social
advantage in the first few generations of men to experi-
ence better living conditions [17,18], thus generating epi-
demiologically stage specific associations between SEP and
immune-related functions, such as pro-inflammatory
states, among men [18,19].
Rapidly developing mega-cities of China may provide a
sentinel for the changes in non-communicable diseases
expected with economic development and inform effective
interventions to reduce the disease burden. In a large sam-
ple of older residents from one of the most developed
mega-cities in China, Guangzhou in southern China, we
assessed the association of SEP at four life stages with
proxies of inflammation (total white blood cell, granulo-
cyte, and lymphocyte counts) and compared models repre-
senting the accumulation, sensitive periods and critical
period hypotheses. Additionally, we hypothesise that
1) higher life course SEP is protective for adult inflamma-
tion, 2) the normal protective effect of social advantage is
obscured in men experiencing rapid socioeconomic
development.
Methods
Sources of data
The Guangzhou Biobank Cohort Study is a collaboration
between the Guangzhou No. 12 Hospital (Guangzhou,
China) and the universities of Hong Kong (Hong Kong,
China) and Birmingham (Birmingham, United Kingdom).
The study has been described previously in detail [20].
Participants were drawn from the Guangzhou Health and
Happiness Association for the Respectable Elders
(GHHARE), a community social and welfare association
unofficially aligned with the municipal government,
where membership is open to anyone aged 50 years or
older for a nominal monthly fee of 4 yuan (US $0.50).
Approximately 7 percent of permanent Guangzhou resi-
dents aged 50 years or more are members of the
GHHARE. Eleven percent of the members were included
in this study, who were capable of consenting, were
ambulatory, and were not receiving treatments which if
discontinued might have resulted in immediate, life-
threatening risk, such as chemotherapy, radiotherapy or
dialysis. Those with less serious chronic illnesses or with
acute illnesses were not specifically excluded from the
study though they may have been less likely to attend.
Participants were recruited in three phases and this study
includes participants recruited in phase 3 only (recruited
between 2006 and 2008), because only phase 3 has
detailed information on childhood socioeconomic posi-
tion and inflammatory markers.
Participants underwent a detailed half-day medical
interview, as well as a physical examination with fasting
blood being sampled. Quantitative haematological analy-
sis was performed using a SYSMEX KX-21 haematology
analyser. The Guangzhou Medical Ethics Committee of
the Chinese Medical Association approved the study
and all participants gave written, informed, consent
prior to participation.
Socioeconomic position across the life course
We used indicators of SEP at four life stages: childhood,
early adult, late adult and current SEP. Childhood SEP
was measured by an index of notable parental posses-
sions that were appropriate to China in the mid-20th
century, based on sociologic accounts of life in southern
China at that time [17]. The items selected were a watch,
a sewing machine, and a bicycle. These items were cate-
gorized, as previously, as none or at least one [21]. As in
other similar studies, we used education and longest-held
occupation as proxies for early and late adult SEP [22].
Early adult SEP was assessed from the highest level of
education (primary or less versus secondary or more).
Occupation was categorised as manual (agricultural
work, factory work, or sales and service) or non-manual
(administrative/managerial, professional/technical, or
military/police). Current SEP was assessed from house-
hold income per head. Household income was recorded
in six categories (<5,000 Yuan, 5000-9,999 Yuan, 10,000-
19,999 Yuan, 20,000-29,999 Yuan, 30,000-49,999 Yuan
and ≥50,000 Yuan). Household income per head was esti-
mated using the mid-point of each income category and
assuming that those in the highest category had an
annual income of 75,000 Yuan. The median household
income per head was used as the cut-off point between
low and high SEP.
Outcome measures
The primary outcome was total white blood cell count
used, as in other studies, as a marker of a pro-inflamma-
tory state [5], and less well functioning immune system.
As we do not have a detailed breakdown of different
white blood cell types, such as macrophages, we also con-
sidered granulocyte and lymphocyte counts as outcomes
because these immune cell sub-populations largely relate
to innate and adaptive immunity respectively. They have
previously been used as markers of inflammation [23,24].
Other measures of inflammation (e.g. C-reactive protein)
were not available.
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Statistical analysis
Multivariable linear regression was used to assess the
adjusted associations of SEP with the outcomes. Following
Mishra et al. [25] we determined the most parsimonious
representation of life course SEP by comparing models for
three different life course hypotheses (the accumulation,
sensitive periods and critical period hypotheses) to a ‘fully
saturated’ model which represents all possible life course
SEP trajectories. As in previous work [26], the accumula-
tion hypothesis was represented by a model representing
the number of life stages with high socioeconomic posi-
tion, and the sensitive periods hypothesis by a model in
which all four measures of SEP were considered as sepa-
rate items in one model adjusted for all four measures of
SEP. The critical period hypothesis was represented by
models in which only one SEP exposure (the critical per-
iod) was included [25]. We used the Akaike Information
Criterion (AIC) to compare models [27]. A smaller AIC
indicates a better model.
We examined whether the outcomes had different asso-
ciations with SEP by sex or age, from the heterogeneity
across subgroups and the significance of an interaction
term obtained from a model including all interaction
terms with age or sex. All models were adjusted for age (in
5 year age groups) and sex. A second set of models was
additionally adjusted for lifestyle factors (smoking, alcohol
use, and physical activity categorized as in Table 1) as
potential mediators and a third set of models additionally
adjusted for body mass index (BMI) as a potential
mediator
Proxies of SEP were unavailable or unclassifiable for
28.7% of the participants, mainly because information on
household income or the longest-held occupation was
missing. Alcohol use or smoking was not available for 2%
of participants. We used multiple imputation for missing
data [28,29]. Socioeconomic position at any stage, alcohol
use and smoking were predicted based on a flexible addi-
tive regression model with predictive mean matching
incorporating age, sex, leg length, seated height, alcohol
use, smoking status, physical activity and SEP at the other
three stages [28]. We imputed missing values 10 times and
analysed each complete dataset separately, then summar-
ized estimates with confidence intervals adjusted for miss-
ing data uncertainty [30]. As a sensitivity analysis, a
complete case analysis without imputation was performed.
We used STATA version 10.0 (STATA Corp., College
Station, TX) and R version 2.12.2 for analysis, imputation
and model estimation.
Results
Of the 10,088 phase 3 participants examined, 1.1% (n =
107) had missing data for total white blood cell, granu-
locyte or lymphocyte counts. Analysis was based on the
remaining 9,981 participants. There were more women
(n = 7,445) than men (n = 2,536) and the women were
younger [mean age 59.2 years (S.D. 7.6)] than the men
[mean age 63.1 years (S.D. 7.6)]. Overall the mean white
blood cell and granulocyte counts were lower in women
than men (Table 1).
The associations of SEP with white blood cell, granulo-
cyte or lymphocyte counts did not vary with age (data not
shown). However, associations of SEP with lymphocyte
count varied with sex, so only sex stratified results have
been presented for this outcome. For white blood cell
count and granulocyte count, the sensitive periods model
performed better than the fully saturated model, accumu-
lation or critical period models (Table 2). The sensitive
periods model shows that some life stages had stronger
negative associations than others with white blood cell
count and granulocyte count; the early adult stage had the
strongest association for both outcomes.
The pattern for lymphocyte cell count was somewhat
different. Associations varied by sex. Table 3 shows that
for both sexes the accumulation and sensitive periods
models did not perform as well as critical period models.
The early adult life stage was a critical period for women,
with a negative association between SEP and lymphocyte
cell count. By contrast, for men, all estimates of associa-
tion between SEP and lymphocyte cell count were positive,
although all confidence intervals included zero.
Additional adjustment for lifestyle factors (smoking,
alcohol use, and physical exercise) attenuated estimates
slightly (see Appendix) but the pattern of associations gen-
erally remained the same. Smoking among men is asso-
ciated with both low SEP and higher lymphocyte count,
hence adjustment for smoking strengthened the positive
association of SEP with lymphocyte count (Appendix).
Further adjustment for BMI (Appendix) produced very
similar results; estimates of association were little changed.
All results were similar in a complete case analysis
(Appendix).
Discussion
Consistent with other studies in developed and developing
settings examining the association between SEP and
inflammation [5-11], we found that SEP was negatively
associated with adult immune cell numbers, particularly
among women. Consistent with the only other study from
a developing country setting, the advantage of higher SEP
for adult inflammation was less marked among men [10].
In general, considering SEP at all four life stages was better
than considering individual life stages (critical periods)
except for lymphocyte cell counts.
This study has a number of strengths. To our knowl-
edge, it is the first study to investigate the role of life
course SEP in later adulthood inflammation in a non-
western, developing setting. Moreover, we explicitly
determined the most parsimonious representation of life
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Table 1 Characteristics (mean value or percentage) of 9,981 Chinese adults (≥ 50 years) by socioeconomic position at four life stages in women and men
from the Guangzhou Biobank Cohort Study, phase 3, 2006-2008
Socio-economic position in:
Childhood(Parental possession of a watch,
sewing machine, and bicycle)
Early Adulthood
(Education*)
Late Adulthood (Occupation) Current (Household Income per
Head)
No. 0 items 1+ items Unknown p † Low High p † Manual Non-manual Unknown p † Low High Unknown p †
Women
Number of participants 7445 4084 3123 238 3057 4386 5225 1211 1009 3025 3141 1279
Mean (SD)
White blood cells (109/L) 7445 6.38(1.5) 6.13(1.5) 6.36(1.4) <0.001 6.52(1.6) 6.10(1.5) <0.001 6.33(1.5) 6.04(1.4) 6.25(1.5) <0.001 6.38(1.6) 6.12(1.5) 6.41(1.6) <0.001
Granulocytes (109/L) 7445 3.79(1.2) 3.62(1.2) 3.71(1.1) <0.001 3.89(1.2) 3.60(1.1) <0.001 3.76(1.2) 3.53(1.1) 3.71(1.2) <0.001 3.79(1.2) 3.60(1.1) 3.84(1.2) <0.001
Lymphocytes (109/L) 7445 2.19(0.6) 2.15(0.6) 2.26(0.6) <0.001 2.22(0.6) 2.14(0.6) <0.001 2.18(0.6) 2.15(0.6) 2.18(0.6) 0.227 2.20(0.6) 2.16(0.6) 2.16(0.6) 0.008
Leg length (cm) 7430 69.7(3.8) 69.8(3.6) 69.8(4.3) 0.393 69.6(3.8) 69.8(3.7) 0.008 69.7(3.7) 69.9(3.6) 69.6(3.8) 0.202 69.6(3.8) 69.8(3.6) 69.6(3.8) 0.099
Sitting height (cm) 7431 83.7(3.6) 85.1(3.1) 84.1(3.7) <0.001 83.1(3.6) 85.1(3.1) <0.001 84.0(3.5) 85.0(3.3) 84.6(3.3) <0.001 83.9(3.5) 85.0(3.2) 83.5(3.7) <0.001
Row%
Age group (years)
50-54 2644 36.0 60.7 3.3 17.9 82.1 65.0 18.5 16.5 36.0 53.0 11.1
55-59 1892 52.7 44.5 2.7 39.1 60.9 69.8 17.2 12.9 39.0 44.2 16.8
60-64 1133 64.9 32.7 2.5 51.5 48.5 73.8 14.7 11.6 46.5 34.6 18.9
65-69 833 74.5 21.5 4.0 63.5 36.4 76.1 13.8 10.1 46.2 29.7 24.1
70-74 621 82.8 13.4 3.9 75.7 24.3 75.0 13.7 11.3 44.8 28.3 26.9
75-79 228 82.0 14.5 3.5 81.1 18.4 75.9 10.5 13.6 49.1 25.0 25.9
80+ 94 80.9 12.8 6.4 <0.001 81.9 18.1 <0.001 81.9 5.3 12.8 <0.001 37.2 34.0 28.7 <0.001
Alcohol use
Never 3981 57.9 39.1 3.1 45.9 54.1 71.7 15.2 13.1 43.8 37.8 18.4
<1/week 2811 49.8 47.1 3.2 33.8 66.2 67.4 18.1 14.5 36.7 48.4 14.9
1-4/week 162 53.1 40.7 6.2 35.2 64.8 72.8 16.7 10.5 35.8 47.5 16.7
5+/week 126 63.5 33.3 3.2 43.7 56.3 70.6 13.5 15.9 34.1 46.8 19.0
Ex-drinker 196 62.8 34.7 2.6 <0.001 50.5 49.5 <0.001 78.1 11.2 10.7 0.001 44.4 35.2 20.4 <0.001
Unknown 169 54.4 40.8 4.7 41.4 57.4 68.6 17.8 13.6 36.1 43.2 20.7
Smoking status
Never 7192 54.5 42.4 3.1 40.1 59.9 70.0 16.4 13.5 40.4 42.5 17.1
Ex-smoker 95 76.8 18.9 4.2 87.4 12.6 77.9 6.3 15.8 46.3 27.4 26.3
Current 106 63.2 28.3 8.5 <0.001 65.1 34.9 <0.001 79.2 12.3 8.5 0.013 55.7 27.4 17.0 <0.001
Unknown 52 48.1 46.2 5.8 38.5 57.7 61.5 17.3 21.2 34.6 51.9 13.5
Physical activity
Inactive 626 55.4 40.7 3.8 42.8 56.9 71.4 15.8 12.8 40.3 38.0 21.7
Minimally active 1848 54.9 42.0 3.1 41.5 58.5 70.1 17.4 12.6 41.7 41.3 16.9
HEPA active$ 4971 54.8 42.1 3.2 0.877 40.7 59.3 0.520 70.1 15.9 14.0 0.450 40.3 43.0 16.7 0.249
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Table 1 Characteristics (mean value or percentage) of 9,981 Chinese adults (?≥? 50 years) by socioeconomic position at four life stages in women and men
from the Guangzhou Biobank Cohort Study, phase 3, 2006-2008 (Continued)
Socio-economic position in
Childhood(Parental possession of a watch,
sewing machine, and bicycle
Early Adulthood
(Education*)
Late Adulthood (Occupation) Current (Household Income per
Head)
No. 0 items 1+ items Unknown p † Low High p † Manual Non-manual Unknown p † Low High Unknown p †
Men
Number of participants 2536 1664 812 60 730 1803 1581 791 164 1131 1035 370
Mean (SD)
White blood cells (109/L) 2536 6.85(1.7) 6.86(1.7) 6.74(1.5) 0.878 7.01(1.7) 6.79(1.7) 0.010 6.87(1.7) 6.75(1.7) 7.15(1.9) 0.021 6.93(1.7) 6.73(1.7) 6.95(1.7) 0.012
Granulocytes (109/L) 2536 4.21(1.4) 4.14(1.4) 4.17(1.1) 0.439 4.38(1.4) 4.11(1.3) <0.001 4.21(1.4) 4.10(1.3) 4.40(1.6) 0.018 4.27(1.4) 4.07(1.3) 4.27(1.4) 0.002
Lymphocytes (109/L) 2536 2.14(0.6) 2.23(0.7) 2.05(0.5) 0.002 2.10(0.6) 2.19(0.7) 0.006 2.16(0.7) 2.17(0.6) 2.23(0.6) 0.389 2.15(0.7) 2.18(0.6) 2.18(0.7) 0.619
Leg length (cm) 2519 75.2(3.8) 75.7(4.2) 75.3(3.7) 0.005 74.6(3.7) 75.6(4.0) <0.001 75.2(3.9) 75.6(4.0) 75.6(3.9) 0.020 75.1(4.0) 75.7(3.8) 75.1(4.0) 0.003
Sitting height (cm) 2520 88.6(3.6) 89.8(3.4) 88.7(3.7) <0.001 87.6(3.5) 89.6(3.4) <0.001 88.8(3.6) 89.3(3.4) 89.7(4.0) <0.001 88.5(3.5) 89.7(3.4) 88.6(3.8) <0.001
Row%
Age group (years)
50-54 346 41.3 56.6 2.0 11.3 88.7 68.8 21.4 9.8 43.9 42.8 13.3
55-59 568 57.0 41.0 1.9 23.6 76.4 67.3 25.4 7.4 44.9 43.0 12.1
60-64 599 65.4 32.2 2.3 25.2 74.6 61.3 32.9 5.8 37.4 47.9 14.7
65-69 470 76.0 22.3 1.7 30.6 69.1 56.8 38.5 4.7 48.5 37.0 14.5
70-74 339 82.3 15.3 2.4 44.5 55.5 58.7 36.3 5.0 48.7 32.2 19.2
75-79 156 78.2 16.0 5.8 51.3 48.1 60.9 32.1 7.1 48.1 35.9 16.0
80+ 58 81.0 13.8 5.2 <0.001 53.4 46.6 <0.001 56.9 37.9 5.2 <0.001 55.2 29.3 15.5 <0.001
Alcohol use
Never 880 68.3 29.9 1.8 30.1 69.9 61.0 32.0 6.9 48.1 36.8 15.1
<1/week 1068 63.2 34.7 2.1 24.4 75.6 61.5 32.0 6.5 41.5 44.4 14.1
1-4/week 176 62.5 34.7 2.8 25.6 74.4 67.6 28.4 4.0 46.0 44.9 9.1
5+/week 271 65.7 32.5 1.8 39.9 60.1 66.4 28.8 4.8 43.9 39.9 16.2
Ex-drinker 93 71.0 21.5 7.5 0.046 37.6 62.4 <0.001 67.7 24.7 7.5 0.323 49.5 34.4 16.1 0.011
Unknown 48 70.8 18.8 10.4 33.3 60.4 52.1 33.3 14.6 39.6 37.5 22.9
Smoking status
Never 940 63.8 34.3 1.9 20.3 79.7 58.3 35.3 6.4 41.0 45.5 13.5
Ex-smoker 675 69.0 28.1 2.8 33.5 66.5 62.2 31.3 6.5 46.2 40.4 13.3
Current 900 65.1 32.9 2.0 0.039 34.3 65.7 <0.001 66.8 27.0 6.2 <0.001 47.6 36.2 16.2 <0.001
Unknown 21 57.1 19.0 23.8 19.0 66.7 57.1 23.8 19.0 28.6 38.1 33.3
Physical activity
Inactive 223 65.9 31.4 2.7 31.8 66.8 68.6 26.0 5.4 48.4 30.9 20.6
Minimally active 866 61.1 36.4 2.5 29.1 70.9 58.8 33.9 7.3 44.3 40.9 14.8
HEPA active$ 1447 68.3 29.5 2.2 0.002 28.1 71.9 0.438 63.5 30.3 6.2 0.021 44.2 42.3 13.5 0.046
* Highest level of education was categorised as low (primary or less) and high (above primary)
# Manual is agricultural worker, factory worker or sales and service, non-manual is administrator/manager, professional/technical or military/disciplined
† p value for linear trend for continuous variables and c2 p value for categorical variables
$ Health enhancing physical activity: vigorous activity at least 3 days a week achieving at least 1500 metabolically equivalent tasks (MET) minutes per week or activity on 7 days of the week achieving at least 3000
MET minutes per week
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Table 2 Associations of high socioeconomic position (compared to low) at four life stages with white cell count and its
differentials, adjusted for agea and sex in 9,981 Chinese adults (≥ 50 years) from the Guangzhou Biobank Cohort
Study, phase 3, 2006-2008
White Blood Cell Count (109/L) Granulocyte Cell Count (109/L)
Δ 95% CI AIC Δ 95% CI AIC
Men and Women
Critical period Modelb
Childhood -0.14 (-0.20, -0.07) 8995 -0.10 (-0.15, -0.04) 4095
Early Adult -0.35 (-0.42, -0.29) 8909 -0.26 (-0.31, -0.21) 4018
Late Adult -0.21 (-0.29, -0.13) 8980 -0.17 (-0.23, -0.11) 4074
Current -0.22 (-0.29, -0.15) 8965 -0.16 (-0.22, -0.11) 4064
Accumulation Modelc 8905 4012
0 0 0
1 -0.19 (-0.29, -0.09) -0.14 (-0.22, -0.06)
2 -0.32 (-0.42, -0.22) -0.23 (-0.31, -0.16)
3 -0.48 (-0.58, -0.38) -0.35 (-0.43, -0.27)
4 -0.51 (-0.65, -0.38) -0.40 (-0.50, -0.29)
Sensitive Periods Modeld 8892 4000
Childhood -0.06 (-0.13, 0.01) -0.03 (-0.09, 0.02)
Early Adult -0.28 (-0.36, -0.20) -0.20 (-0.26, -0.14)
Late Adult -0.08 (-0.17, 0.002) -0.08 (-0.14, -0.01)
Current -0.12 (-0.19, -0.05) -0.09 (-0.15, -0.04)
Fully Saturated Modele 8905 4015
Abbreviations: CI Confidence Interval; AIC Akaike Information Criterion
Bold numbers indicate P < 0.05 for coefficients or best fitting model for AICs
* Test for interaction with sex significant at p < 0.05 level
aAge in five year age groups. bEstimates for SEP at each individual life stage adjusted for age and sex but unadjusted for SEP at other life stages. cNumber of
periods in high SEP adjusted for age and sex. dMutually adjusted for SEP at other life stages and adjusted for age and sex. eIncludes SEP at all four life stages
and all possible interactions between all four measures of SEP. Also adjusted for age and sex
Table 3 Associations of high socioeconomic position (compared to low) at four life stages with lymphocyte cell count
(109/L) by sex, adjusted for agea in 9,981 Chinese adults (≥ 50 years) from the Guangzhou Biobank Cohort Study,
phase 3, 2006-2008
Women (n = 7,445) Men (n = 2,536)
Δ 95% CI AIC Δ 95% CI AIC
Critical period Modelb
Childhood -0.04 (-0.07, -0.01) -7874 0.03 (-0.03, 0.08) -2277
Early Adult -0.08 (-0.11, -0.05) -7894 0.03 (-0.02, 0.09) -2277
Late Adult -0.03 (-0.07, 0.01) -7871 0.04 (-0.01, 0.10) -2279
Current -0.04 (-0.07, -0.01) -7874 0.01 (-0.05 0.07) -2277
Accumulation Modelc -7885 -2274
0 0 0
1 -0.02 (-0.07, 0.02) 0.02 (-0.07, 0.11)
2 -0.05 (-0.10, -0.01) 0.05 (-0.03, 0.13)
3 -0.10 (-0.14, -0.05) 0.04 (-0.05, 0.12)
4 -0.09 (-0.15, -0.03) 0.10 (-0.01, 0.21)
Sensitive Periods Modeld -7891 -2274
Childhood -0.02 (-0.05, 0.01) 0.02 (-0.03, 0.08)
Early Adult -0.07 (-0.10, -0.04) 0.02 (-0.04, 0.08)
Late Adult 0.00 (-0.04, 0.04) 0.04 (-0.02, 0.10)
Current -0.01 (-0.05, 0.02) 0.00 (-0.06, 0.06)
Fully Saturated Modele -7882 -2262
Abbreviations: CI Confidence Interval; AIC Akaike Information Criterion
Bold numbers indicate P < 0.05 for coefficients or best fitting model for AICs
aAge in five year age groups. bEstimates for SEP at each individual life stage adjusted for age but unadjusted for SEP at other life stages. cNumber of periods in
high SEP adjusted for age. dMutually adjusted for SEP at other life stages and adjusted for age eIncludes SEP at all four life stages and all possible interactions
between all four measures of SEP. Also adjusted for age
West et al. BMC Public Health 2012, 12:269
http://www.biomedcentral.com/1471-2458/12/269
Page 6 of 12
course SEP. The large sample size allowed sex-specific
analysis. Nevertheless, there are limitations. First, it is a
cross-sectional study with recalled SEP, which may be
imprecise, although most likely non-differential. Second,
in a cross-sectional design reverse causality must be con-
sidered although it is unlikely that inflammation has a
causal effect on life course SEP. Third, there may have
been gender bias in the allocation of resources within
families, most likely favouring boys and men, which may
have mitigated the disadvantages of low SEP. However it
is unclear why this should have mitigated the effect of
SEP for lymphocytes but not for white blood cells and
granulocytes. Fourth, our cohort may not be fully popula-
tion representative. However, prevalence of certain mor-
bidities, such as diabetes, were similar to those in a
representative sample of urban Chinese [31]. Fifth, survi-
vor bias is possible, which may have limited participants’
socioeconomic and health diversity, biasing results
towards the null. If survivorship were an issue we would
have expected differences in associations by age, of which
there was no evidence. Sixth, we did not explicitly con-
sider the life course effects of social mobility since these
are particularly hard to define and test clearly. Inter- and
intra-generational mobility, upward and downward mobi-
lity are all potential risk factors.
Seventh, a single measurement of white blood cells
and differential cell counts may not accurately reflect
long-term immune function or inflammation. However,
white blood cell count is used as a marker of immune
status in clinical settings and is a well-established and
routinely-used marker of systemic inflammation [32].
White blood cell count is associated with disease risk
and predicts disease outcome [33,34]. Eighth, although
we report associations between SEP and differential
white blood cell counts, clinical significance remains to
be determined. Within the normal range, elevated white
blood cell counts are associated with risk factors for
chronic diseases, such as cardiovascular disease [32,35].
White blood cell counts can be conceptualised as a
mixed marker of exposure and response, even a rela-
tively small shift towards a healthier inflammation-
immunological profile might have significant public
health benefits at the population level [33,34]. Ninth,
acute infection, trauma and underlying chronic disease
or medication could be mediators. There is no evidence
to suggest that participants were experiencing infection
during the assessment process, nor significant trauma.
Although only those with life-threatening illness were
specifically excluded, those experiencing significant
acute infection or trauma were less likely to attend this
study, which should have minimized any bias from this
source. We also performed descriptive analysis of the
data to detect and exclude outliers, which may have
resulted from unknown underlying disease, medication,
or recording error.
One possible explanation for the association of low
SEP with inflammation is via current health behaviour
linked to inflammation [5,36-38]. Although we did not
perform formal tests of mediation, we did adjust for
smoking, alcohol consumption, physical activity and
BMI in separate models (Appendix), which had little
effect among women, but among men, this attenuated
the negative association of early adult SEP with white
blood cell and granulocyte counts and strengthened the
positive association of early adult SEP with lymphocyte
counts. This suggests that any associations are unlikely
to be driven by adult health behaviour in women,
though these may obscure negative associations of early
adult SEP with inflammatory markers in men.
Low SEP may increase exposure to pro-inflammatory
agents, such as microbial pathogens, pollutants or
adverse work conditions. Mechanisms for increased
exposure or vulnerability to pathogens in low SEP
groups include earlier and/or greater lifetime exposure
due to adverse living conditions, such as overcrowding,
and increased susceptibility to primary infection through
nutritional deficiencies, or stress-related immune dys-
function [3]. A gender bias may have protected low SEP
men from such exposures and adverse work conditions,
although it is not clear why the effects should be most
obvious for lymphocytes. Lower birth weight amongst
those with low childhood SEP is another possible expla-
nation, but birth weight is not available for our partici-
pants. Birth weight is inversely associated with
inflammatory markers [6,39]. However, birth weight
appears to be less relevant in developing country set-
tings such as ours [40], and there is no reason why birth
weight should have sex-specific effects on some white
cell sub-types.
An alternative explanation is that better early life con-
ditions would be expected to promote development of
the adaptive immune system, particularly of the thymus,
[41] whose development takes place in early life [41]
and which is sensitive to malnutrition, micro-nutrient
deficiencies and infections during growth and develop-
ment [42-44]. Moreover, the same exposure would also
allow upregulation of the gonadotropic axis resulting in
sex-specific effects on some immune cell sub-popula-
tions [45-47], particularly those relating to adaptive
immunity. Consistent with this mechanism we have pre-
viously observed similar sex-specific associations, in the
Guangzhou Biobank Cohort Study, of childhood stress
with white cell count [48] and of childhood diet with
lymphocytes but not granulocytes [19]. However, we do
not have measurements that would allow proof of this
mechanism.
West et al. BMC Public Health 2012, 12:269
http://www.biomedcentral.com/1471-2458/12/269
Page 7 of 12
Table 4 Associations of high socioeconomic position compared to low at four life stages with white cell count and
granulocyte count, adjusted for agea, sex and lifestyle factors in 9,981 Chinese adults (≥50 years) from the Guangzhou
Biobank Cohort Study, phase 3, 2006-2008
White Blood Cell Count (109/L) Granulocyte Cell Count (109/L)
Δ 95% CI AIC Δ 95% CI AIC
Men and Women
Critical Period Modelb
Childhood -0.13 (-0.19, -0.06) 8789 -0.09 (-0.14, -0.04) 3967
Early Adult -0.31* (-0.38, -0.24) 8725 -0.23 (-0.29, -0.18) 3907
Late Adult -0.18* (-0.27, -0.10) 8779 -0.16 (-0.22, -0.09) 3951
Current -0.18 (-0.25, -0.12) 8769 -0.15 (-0.20, -0.09) 3944
Accumulation Modelc 8722 3901
0 0 0
1 -0.17 (-0.27, -0.07) -0.13 (-0.21, -0.05)
2 -0.28 (-0.37, -0.18) -0.21 (-0.28, -0.13)
3 -0.42 (-0.52, -0.32) -0.32 (-0.40, -0.24)
4 -0.46 (-0.59, -0.32) -0.37 (-0.47, -0.26)
Sensitive Periods Modeld 8713 3892
Childhood -0.06 (-0.13, 0.01) -0.04 (-0.09, 0.02)
Early Adult -0.24 (-0.32, -0.17) -0.18 (-0.24, -0.12)
Late Adult -0.08 (-0.16, 0.01) -0.07 (-0.14, -0.01)
Current -0.10 (-0.18, -0.03) -0.08 (-0.14, -0.02)
Fully Saturated Modele 8725 3907
Abbreviations: CI Confidence Interval; AIC Akaike Information Criterion
Bold numbers indicate P < 0.05 for coefficients or best fitting model for AICs * Test for interaction with sex significant at p < 0.05 level
aAge in five year age groups. bEstimates for SEP at each individual life stage adjusted for age, sex, smoking, alcohol use, and physical activity but unadjusted for
SEP at other life stages. cNumber of periods in high SEP adjusted for age, sex, smoking, alcohol use, and physical activity. dMutually adjusted for SEP at other life
stages and adjusted for age, sex, smoking, alcohol use, and physical activity. eIncludes SEP at all four life stages and all possible interactions between all four
measures of SEP. Also adjusted for age, sex, smoking, alcohol use, and physical activity
Table 5 Associations of high socioeconomic position (compared to low) at four life stages with lymphocyte cell count
(109/L) by sex, adjusted for agea and lifestyle factors in 9,981 Chinese adults (≥50 years) from the Guangzhou Biobank
Cohort Study, phase 3, 2006-2008
Women (n = 7,445) Men (n = 2,536)
Δ 95% CI AIC Δ 95% CI AIC
Critical period Modelb
Childhood -0.03 (-0.06, -0.01) -7876 0.03 (-0.02, 0.09) -2354
Early Adult -0.08 (-0.11, -0.05) -7894 0.07 (0.02, 0.13) -2360
Late Adult -0.03 (-0.07, 0.01) -7873 0.06 (0.003, 0.11) -2358
Current -0.03 (-0.06, -0.001) -7876 0.03 (-0.02, 0.09) -2355
Accumulation Modelc -7885 -2357
0 0 0
1 -0.02 (-0.07, 0.02) 0.04 (-0.05, 0.12)
2 -0.05 (-0.10, -0.01) 0.08 (0.004, 0.16)
3 -0.09 (-0.13, -0.04) 0.08 (0.001, 0.17)
4 -0.09 (-0.14, -0.03) 0.15 (0.03, 0.26)
Sensitive Periods Modeld -7891 -2357
Childhood -0.02 (-0.05, 0.01) 0.02 (-0.03, 0.08)
Early Adult -0.07 (-0.10, -0.03) 0.06 (-0.01, 0.12)
Late Adult 0.00 (-0.04, 0.04) 0.04 (-0.02, 0.10)
Current -0.01 (-0.04, 0.02) 0.01 (-0.05, 0.07)
Fully Saturated Modele -7881 -2345
Abbreviations: CI Confidence Interval; AIC Akaike Information Criterion
Bold numbers indicate P < 0.05 for coefficients or best fitting model for AICs
aAge in five year age groups. bEstimates for SEP at each individual life stage adjusted for age, smoking, alcohol use, and physical activity but unadjusted for SEP
at other life stages. cNumber of periods in high SEP adjusted for age, smoking, alcohol use, and physical activity. dMutually adjusted for SEP at other life stages
and adjusted for age, smoking, alcohol use, and physical activity. eIncludes SEP at all four life stages and all possible interactions between all four measures of
SEP. Also adjusted for age, smoking, alcohol use, and physical activity
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Table 6 Associations of high socioeconomic position (compared to low) at four life stages with white cell count and
granulocyte count, adjusted for agea, sex and lifestyle factors and body mass index in 9,981 Chinese adults (≥50
years) from the Guangzhou Biobank Cohort Study, phase 3, 2006-2008
White Blood Cell Count (109/L) Granulocyte Cell Count (109/L)
Δ 95% CI AIC Δ 95% CI AIC
Men and Women
Critical period Modelb
Childhood -0.13 (-0.19, -0.06) 8248 -0.09 (-0.14, -0.04) 3675
Early Adult -0.31 (-0.38, -0.24) 8206 -0.24 (-0.29, -0.18) 3631
Late Adult -0.20 (-0.27, -0.12) 8239 -0.17 (-0.23, -0.10) 3659
Current -0.20 (-0.27, -0.14) 8223 -0.16 (-0.21, -0.11) 3646
Accumulation Modelc 3611
0 0 8186.0 0
1 -0.19 (-0.29, -0.09) -0.14 (-0.22, -0.06)
2 -0.28 (-0.37, -0.18) -0.21 (-0.29, -0.14)
3 -0.40 (-0.50, -0.30) -0.31 (-0.39, -0.23)
4 -0.42 (-0.56, -0.29) -0.35 (-0.45, -0.24)
Sensitive Periods Modeld 8185.9 3608
Childhood -0.06 (-0.13, 0.01) -0.04 (-0.09, 0.02)
Early Adult -0.18 (-0.25, -0.10) -0.14 (-0.20, -0.08)
Late Adult -0.08 (-0.16, 0.00) -0.08 (-0.14, -0.02)
Current -0.12 (-0.20, -0.05) -0.10 (-0.15, -0.05)
Fully Saturated Modele 8198 3624
Abbreviations: CI Confidence Interval; AIC Akaike Information Criterion
Bold numbers indicate P < 0.05 for coefficients or best fitting model for AICs
aAge in five year age groups. bEstimates for SEP at each individual life stage adjusted for age, sex, smoking, alcohol use, and physical activity and body mass
index but unadjusted for SEP at other life stages. cNumber of periods in high SEP adjusted for age, sex, smoking, alcohol use, and physical activity and body
mass index. dMutually adjusted for SEP at other life stages and adjusted for age, sex, smoking, alcohol use, and physical activity and body mass index. eIncludes
SEP at all four life stages and all possible interactions between all four measures of SEP. Also adjusted for age, sex, smoking, alcohol use, and physical activity
Table 7 Associations of high socioeconomic position (compared to low) at four life stages with lymphocyte cell count
(109/L) by sex, adjusted for agea, lifestyle factors and body mass index in 9,981 Chinese adults(≥50 years) from the
Guangzhou Biobank Cohort Study, phase3, 2006-2008
Women (n = 7,445) Men (n = 2,536)
Δ 95% CI AIC Δ 95% CI AIC
Critical period Modelb
Childhood -0.03 (-0.06, -0.01) -8283 0.03 (-0.02, 0.09) -2438
Early Adult -0.08 (-0.11, -0.05) -8288 0.07 (0.02, 0.13) -2443
Late Adult -0.03 (-0.06, 0.01) -8278 0.05 (0.00, 0.11) -2440
Current -0.03 (-0.06, -0.01) -8281 0.03 (-0.02, 0.09) -2438
Accumulation Modelc -8284 -2439
0 0* 0*
1 -0.03 (-0.08, 0.01) 0.02 (-0.06, 0.10)
2 -0.04 (-0.08, 0.002) 0.07 (-0.01, 0.15)
3 -0.07 (-0.12, -0.02) 0.07 (-0.02, 0.15)
4 -0.06 (-0.12, -0.0003) 0.13 (0.02, 0.24)
Sensitive Periods Modeld -8285 -2440
Childhood -0.02 (-0.05, 0.01) 0.02 (-0.04, 0.08)
Early Adult -0.04 (-0.07, -0.01) 0.06 (0.002, 0.12)
Late Adult 0.01 (-0.03, 0.05) 0.03 (-0.03, 0.09)
Current -0.01 (-0.04, 0.02) 0.00 (-0.06, 0.06)
Fully Saturated Modele -8274 -2428
Abbreviations: CI Confidence Interval; AIC Akaike Information Criterion
Bold numbers indicate P < 0.05 for coefficients or best fitting model for AICs
aAge in five year age groups. bEstimates for SEP at each individual life stage adjusted for age, smoking, alcohol use, and physical activity and body mass index
but unadjusted for SEP at other life stages. cNumber of periods in high SEP adjusted for age, smoking, alcohol use, and physical activity and body mass index.
dMutually adjusted for SEP at other life stages and adjusted for age, smoking, alcohol use, and physical activity and body mass index. eIncludes SEP at all four life
stages and all possible interactions between all four measures of SEP. Also adjusted for age, smoking, alcohol use, and physical activity
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Table 8 Associations of high socioeconomic position (compared to low) at four life stages with white cell count and its
differentials, adjusted for agea and sex Chinese adults (≥50 years) from the Guangzhou Biobank Cohort Study, phase
3, 2006-2008 including complete cases only
White Blood Cell Count (109/L) Granulocyte Cell Count (109/L)
N Δ 95% CI AIC N Δ 95% CI AIC
Men and Women
Critical period Modelb
Childhood 9683 -0.14 (-0.21, -0.07) 8769 9683 -0.10 (-0.15, -0.04) 4038
Early Adult 9976 -0.35 (-0.42, -0.29) 8906 9976 -0.26 (-0.31, -0.21) 4018
Late Adult 8808 -0.23 (-0.31, -0.15) 7901 8808 -0.19 (-0.25, -0.12) 3575
Current 8332 -0.23 (-0.30, -0.16) 7446 8332 -0.17 (-0.23, -0.12) 3362
Accumulation Modelc 6327 2872
0 7117 0 7117 0.00
1 7117 -0.19 (-0.31, -0.07) 7117 -0.18 (-0.28, -0.08)
2 7117 -0.38 (-0.50, -0.26) 7117 -0.30 (-0.40, -0.21)
3 7117 -0.54 (-0.66, -0.42) 7117 -0.43 (-0.52, -0.33)
4 7117 -0.53 (-0.69, -0.38) 7117 -0.42 (-0.55, -0.30)
Sensitive Periods Modeld 6299 2851
Childhood 7112 -0.05 (-0.13, 0.03) 7112 -0.03 (-0.09, 0.04)
Early Adult 7112 -0.35 (-0.44, -0.26) 7112 -0.25 (-0.32, -0.18)
Late Adult 7112 -0.07 (-0.16, 0.02) 7112 -0.07 (-0.14, -0.002)
Current 7112 -0.12 (-0.20, -0.05) 7112 -0.10 (-0.16, -0.03)
Fully Saturated Model e 7112 6310 7112 2864
Abbreviations: CI Confidence Interval; AIC Akaike Information Criterion
Bold numbers indicate P < 0.05 for coefficients or best fitting model for AICs
* Test for interaction with sex significant at p < 0.05 level
aAge in five year age groups. bEstimates for SEP at each individual life stage adjusted for age and sex but unadjusted for SEP at other life stages. cNumber of
periods in high SEP adjusted for age and sex. dMutually adjusted for SEP at other life stages and adjusted for age and sex. eIncludes SEP at all four life stages
and all possible interactions between all four measures of SEP. Also adjusted for age and sex
Table 9 Associations of high socioeconomic position (compared to low) at four life stages with lymphocyte cell count
(109/L) by sex, adjusted for agea in 9,981 Chinese adults (≥50 years) from the Guangzhou Biobank Cohort Study,
phase 3, 2006-2008 including complete cases only
Women (n = 7,445) Men (n = 2,536)
N Δ 95% CI AIC N Δ 95% CI AIC
Critical period Modelb
Childhood 7207 -0.04 (-0.07, -0.01) -7619 2476 0.03 (-0.03, 0.08) -2206
Early Adult 7443 -0.08 (-0.11, -0.05) -7893 2533 0.03 (-0.02, 0.09) -2274
Late Adult 6436 -0.03 (-0.07, 0.01) -6835 2372 0.04 (-0.02, 0.09) -2118
Current 6166 -0.04 (-0.07, -0.01) -6589 2166 0.01 (-0.05, 0.06) -1982
Accumulation Modelc -5520 -1783
0 0.00 1981 0.00
1 5136 0.02 (-0.04, 0.07) 1981 0.03 (-0.08, 0.13)
2 5136 -0.04 (-0.10, 0.01) 1981 0.07 (-0.03, 0.16)
3 5136 -0.10 (-0.15, -0.04) 1981 0.08 (-0.02, 0.17)
4 5136 -0.07 (-0.14, -0.002) 1981 0.07 (-0.05, 0.20)
Sensitive Periods Modeld -5512 -1782
Childhood 5131 -0.03 (-0.06, 0.01) 1981 0.03 (-0.03, 0.09)
Early Adult 5131 -0.08 (-0.12, -0.04) 1981 -0.01 (-0.08, 0.06)
Late Adult 5131 0.02 (-0.03, 0.06) 1981 0.03 (-0.03, 0.09)
Current 5131 -0.01 (-0.05, 0.02) 1981 -0.01 (-0.06, 0.05)
Fully Saturated Modele 5131 -7222 1981 -7222
Abbreviations: CI Confidence Interval; AIC Akaike Information Criterion
Bold numbers indicate P < 0.05 for coefficients or best fitting model for AICs
aAge in five year age groups. bEstimates for SEP at each individual life stage adjusted for age but unadjusted for SEP at other life stages. cNumber of periods in
high SEP adjusted for age. dMutually adjusted for SEP at other life stages and adjusted for age. eIncludes SEP at all four life stages and all possible interactions
between all four measures of SEP. Also adjusted for age
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Conclusions
Socioeconomic position was inversely associated with
white blood cell differential counts, as a marker of
inflammation, with a clearer and more consistent asso-
ciation among women than men. Environmentally and
inter-generationally driven changes to the gonadotropic
axis may obscure the normally protective effect of social
advantage in the first few generations of men, but not
women, to experience better living conditions. Given the
links between the immune system, inflammation and
chronic disease, this provides a biological mechanism
between SEP and the pathophysiological genesis of
chronic disease. Understanding such mechanisms for
populations experiencing the epidemiological transition
is of public health significance.
Appendix
Associations of socioeconomic position with markers of
inflammation, additionally adjusted for lifestyles factors
(smoking, alcohol use and physical exercise), are shown
below: associations with white cell counts and granulo-
cyte counts are shown in Table 4 and sex-specific asso-
ciations with lymphocyte counts are shown in Table 5.
Associations further adjusted for body mass index are
shown in Table 6 (for white cell count and granulocyte
count) and Table 7 (lymphocyte count). Results from the
complete case analysis are shown in below in Table 8
(white cell count and granulocyte count) and Table 9
(lymphocyte count).
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